485 related articles for article (PubMed ID: 17845689)
1. Increased serum gamma-glutamyl-transpeptidase concentration is associated with nonalcoholic steatosis and not with cholestasis in patients with chronic hepatitis C.
Benini F; Pigozzi MG; Baisini O; Romanini L; Ahmed H; Pozzi A; Ricci C; Lanzini A
J Gastroenterol Hepatol; 2007 Oct; 22(10):1621-6. PubMed ID: 17845689
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
3. Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C.
Hwang SJ; Luo JC; Lai CR; Chu CW; Tsay SH; Lu CL; Wu JC; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jul; 63(7):527-35. PubMed ID: 10934805
[TBL] [Abstract][Full Text] [Related]
4. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.
Tahan V; Canbakan B; Balci H; Dane F; Akin H; Can G; Hatemi I; Olgac V; Sonsuz A; Ozbay G; Yurdakul I; Senturk H
Hepatogastroenterology; 2008; 55(85):1433-8. PubMed ID: 18795706
[TBL] [Abstract][Full Text] [Related]
5. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
[TBL] [Abstract][Full Text] [Related]
6. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
7. [Gamma glutamly transpeptidase in chronic anicteric hepatopathies].
Magris D; Mian G; Minutillo S; D'Agnolo B
Minerva Med; 1975 Sep; 66(56):2776-80. PubMed ID: 241034
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum gamma-glutamyltranspeptidase activity is frequent in chronic hepatitis C, and is associated with insulin resistance.
Benini F; Pigozzi MG; Pozzi A; Bercich L; Reggiani A; Quattrocchi D; Distefano L; Donati P; Cesana BM; Lanzini A
Dig Liver Dis; 2009 Aug; 41(8):586-90. PubMed ID: 19131283
[TBL] [Abstract][Full Text] [Related]
10. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
[TBL] [Abstract][Full Text] [Related]
11. Serum gamma-glutamyl transpeptidase: its clinical significance.
Pár A; Mestyán I; Kádas I; Balázs M; Gógl A
Acta Med Acad Sci Hung; 1976; 33(4):309-19. PubMed ID: 23644
[TBL] [Abstract][Full Text] [Related]
12. Serum cholestasis markers as predictors of early outcome after liver transplantation.
Ben-Ari Z; Weiss-Schmilovitz H; Sulkes J; Brown M; Bar-Nathan N; Shaharabani E; Yussim A; Shapira Z; Tur-Kaspa R; Mor E
Clin Transplant; 2004 Apr; 18(2):130-6. PubMed ID: 15016125
[TBL] [Abstract][Full Text] [Related]
13. Serum bile acids and rountine liver function tests in patients with chronic liver disease and cholestasis.
Collins DM; Tongeren AV; Cook HB; Campbell CB
N Z Med J; 1979 Jun; 89(637):432-4. PubMed ID: 289016
[TBL] [Abstract][Full Text] [Related]
14. A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT.
Tavian D; Degiorgio D; Roncaglia N; Vergani P; Cameroni I; Colombo R; Coviello DA
Dig Liver Dis; 2009 Sep; 41(9):671-5. PubMed ID: 19261551
[TBL] [Abstract][Full Text] [Related]
15. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
16. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
[TBL] [Abstract][Full Text] [Related]
17. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ
Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis in Iranian patients with chronic hepatitis C.
Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR
Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
[TBL] [Abstract][Full Text] [Related]
20. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
